Junior Research Fellow at Magdalene College, Cambridge ancient DNA, evolutionary genetics, and the history of human disease
I study how thousands of years of human migration, lifestyle change and infectious disease have shaped the genetic architecture of the diseases we live with today. My work sits at the meeting point of ancient DNA, statistical genetics and evolutionary medicine.
I am a Neville Junior Research Fellow at Magdalene College and work in Richard Durbin's group in the Department of Genetics at Cambridge. I read Natural Sciences at Clare College, Cambridge, and completed my PhD at Pembroke College in 2023 under Eske Willerslev, with co-supervision from Rasmus Nielsen (UC Berkeley) and Daniel Lawson (Bristol). Before starting my JRF I held postdoctoral positions in the Cambridge Department of Genetics and at the GLOBE Institute in Copenhagen.
I was first or joint-first author on three of the four papers that appeared on the cover of Nature in January 2024, including the lead study tracing the elevated risk of multiple sclerosis in northern Europe to positive selection in Bronze Age steppe pastoralists. The papers were covered widely in the international press: BBC television and radio, ITV News, the Guardian, the New York Times, the Washington Post, the Financial Times, the Economist, and several hundred further outlets.
My research aims to answer two fundamental questions: how has human evolution produced populations harbouring high levels of disease-associated genetics variants? And why are these genetic variants poorly suited to modern environments? This is particularly relevant in the case of autoimmune diseases like multiple sclerosis. Ultimately, I want to use this information to predict, prevent and treat autoimmune conditions today. Answering these questions requires looking deep into the past at our ancestors' DNA, how they lived, and what infections they were living alongside.
Detecting and dating signatures of natural selection across tens of thousands of ancient genomes.
Building polygenic risk scores in ancient and modern populations. I am interested in how local ancestry information can improve polygenic risk scores.
Why are diseases such as MS, rheumatoid arthritis and type 1 diabetes so common in northern Europe? I'm interested in where the genetic risk variants underlying these diseases originated, and why they are so common today.
Using computer modelling to investigate the Red Queen dynamics of human-pathogen co-evolution, particularly in the HLA region of the human genome.
My current work is moving in two directions. The first broadens the same evolutionary lens beyond autoimmunity to cardio-metabolic disease, biomarkers and other complex traits, and develops new methods for tracing fine-scale ancestry through deep time. The second is more translational: testing long-standing hypotheses about why modern environments misfire on ancient immune systems, with implications for public health and personalised medicine.
See also Google Scholar and ORCID.
§ denotes joint first authorship.
The 2024 Nature papers were covered in over 700 pieces of international media. A representative selection below.
Coverage spanned more than 700 pieces in 30+ countries.
For research enquiries, collaborations, or media requests please write to the address below.